tiprankstipranks
Trending News
More News >
Arkema (FR:AKE)
:AKE
France Market
Advertisement

Arkema (AKE) Technical Analysis

Compare
30 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Arkema’s (AKE) Moving Averages Convergence Divergence (MACD) indicator is -1.25, suggesting Arkema is a Sell.
Arkema’s (AKE) 20-Day exponential moving average is 52.75, while Arkema’s (AKE) share price is €52.7, making it a Sell.
Arkema’s (AKE) 50-Day exponential moving average is 55.51, while Arkema’s (AKE) share price is €52.7, making it a Sell.

Arkema (AKE) Pivot Points

Oct 25, 2025, 11:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
50.88
51.22
51.88
52.22
52.88
53.22
53.88
Fibonacci
51.22
51.60
51.83
52.22
52.60
52.83
53.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Arkema (AKE) Moving Averages

Oct 25, 2025, 11:30 PM
Period
Simple
Exponential
MA5
52.32Buy
52.25Buy
MA10
51.27Buy
52.04Buy
MA20
52.32Buy
52.75Sell
MA50
56.55Sell
55.51Sell
MA100
59.28Sell
58.45Sell
MA200
63.99Sell
63.06Sell
Arkema’s (AKE) 10-Day exponential moving average is 52.04, while Arkema’s (AKE) share price is €52.7, making it a Buy.
Arkema’s (AKE) 100-Day exponential moving average is 58.45, while Arkema’s (AKE) share price is €52.7, making it a Sell.
Arkema’s (AKE) stock price is €52.7 and Arkema’s (AKE) 50-day simple moving average is 56.55, creating a Sell signal.
Arkema’s (AKE) stock price is €52.7 and Arkema’s (AKE) 100-day simple moving average is 59.28, creating a Sell signal.
Arkema’s (AKE) stock price is €52.7 and Arkema’s (AKE) 200-day simple moving average is 63.99, creating a Sell signal.

Arkema (AKE) Technical Indicators

Oct 25, 2025, 11:30 PM
Name
Value
Implied Action
RSI (14)
45.52
Neutral
STOCH (9,6)
95.81
Sell
STOCHRSI (14)
57.63
Neutral
MACD (12,26)
-1.25
Sell
ADX (14)
33.48
Neutral
Williams %R
-37.63
Buy
CCI (14)
19.92
Neutral
ATR (14)
1.43
-
Ultimate Oscillator
67.51
Neutral
ROC
-4.53
Sell
Arkema’s (AKE) Relative Strength Index (RSI) is 45.52, creating a Neutral signal.
Arkema’s (AKE) Trend Strength Indicator (ADX) is 33.48, creating a Neutral signal.
Arkema’s (AKE) Commodity Channel Index (CCI) is 19.92, creating a Neutral signal.
Arkema’s (AKE) Price Rate of Change (ROC) is -4.53, creating a Sell signal.

FAQ

Is AKE a Buy, Hold, or Sell?
Based on AKE’s technical indicators, AKE is a Sell.
    What is AKE’s RSI (14)?
    AKE’s RSI (14) is 45.52, which suggests AKE is a Neutral.
      What is AKE’s MACD?
      AKE’s MACD is -1.25, which suggests AKE is a Sell.
        What is AKE’s 5-day moving average?
        AKE’s 5-day moving average is 52.32, which suggests AKE is a Buy.
          What is AKE’s 20-day moving average?
          AKE 20-day moving average is 52.32, which suggests AKE is a Buy.
            What is AKE’s 50-day moving average?
            AKE’s 50-day moving average is 56.55, which suggests AKE is a Sell.
              What is AKE’s 200-day moving average?
              AKE’s 200-day moving average is 63.99, which suggests AKE is a Sell.
                What is AKE’s Williams % R (14)?
                AKE’s Williams % R (14) is -37.63, which suggests AKE is a Buy.
                  What is AKE’s CCI (14)?
                  AKE’s CCI (14) is 19.92, which suggests AKE is a Neutral.
                    What is the share price of Arkema?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis